HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$2.43
Day range
$2.50 - $2.76
Year range
$2.30 - $35.60
Market cap
11.46M USD
Avg Volume
30.98K
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 11.75M | 144.77% |
Operating expense | 8.83M | -31.93% |
Net income | -3.19M | 77.05% |
Net profit margin | -27.13 | 90.62% |
Earnings per share | — | — |
EBITDA | -1.93M | 82.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.56M | -54.50% |
Total assets | 38.91M | -39.14% |
Total liabilities | 25.44M | -49.81% |
Total equity | 13.46M | — |
Shares outstanding | 2.23B | — |
Price to book | 243.00 | — |
Return on assets | -17.29% | — |
Return on capital | -23.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.19M | 77.05% |
Cash from operations | -8.61M | -272.51% |
Cash from investing | 11.16M | 154.70% |
Cash from financing | -1.11M | -109.45% |
Net change in cash | 1.60M | 146.08% |
Free cash flow | -5.47M | -126.22% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
28
